デフォルト表紙
市場調査レポート
商品コード
1469108

細胞治療技術市場:2024-2034年

Cell Therapy Technologies Market Report 2024-2034

出版日: | 発行: Visiongain Reports Ltd. | ページ情報: 英文 305 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: GBPを日本円(税抜)に換算
本日の銀行送金レート: 1GBP=204.52円

ご注意:
Single UserとTeamライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

細胞治療技術市場:2024-2034年
出版日: 2024年04月18日
発行: Visiongain Reports Ltd.
ページ情報: 英文 305 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の細胞治療技術の市場規模は、2034年にかけてCAGR 10.7%で成長すると予測されています。

オートメーションとロボティクスの製造プロセスへの統合が業界の成長を牽引:

製造部門におけるオートメーションとロボティクスの融合が、細胞治療技術の採用を後押ししています。この融合は効率性、拡張性、再現性を高めると同時に、汚染リスクを軽減します。クローズドシステムバイオプロセシング技術の活用が進むと、無菌性と安全性が強化され、製造上の課題がさらに解決されます。

とはいえ、莫大な開発費、複雑な製造工程、規制の複雑さ、制限された償還政策などの障害が、産業拡大の潜在的な障害となっています。これらの障害を克服するために、品質管理とプロセスの最適化を目的とした最先端の分析ツールに対する需要が高まっています。

革新的なアッセイ、イメージング技術、データ解析の統合は、細胞製品のリアルタイムのモニタリングと特性評価を容易にし、それによって高い有効性と安全性を保証します。さらに、先駆的なバイオマテリアルとスキャフォールドに焦点を当てることで、細胞導入と生着が促進され、細胞治療技術の魅力が増しています。規制の進展や業界ステークホルダーと研究機関間の連携がイノベーションを促進し、細胞治療技術の実験室環境から臨床応用への移行を加速させています。

当レポートでは、世界の細胞治療技術の市場を調査し、市場概要、市場成長への影響因子および市場機会の分析、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 レポート概要

第2章 エグゼクティブサマリー

第3章 市場概要

  • 主な調査結果
  • 市場力学
    • 市場牽引要因
    • 市場抑制要因
    • 市場機会
  • COVID-19の影響分析
  • ポーターのファイブフォース分析
  • PEST分析

第4章 細胞治療技術市場の分析:製品別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 血清、培地、試薬
  • 細胞工学製品
  • 細胞培養容器
  • 装置
  • システム・ソフトウェア
  • その他
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第5章 細胞治療技術市場の分析:細胞タイプ別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • T細胞
  • 幹細胞
  • その他
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第6章 細胞治療技術市場の分析:プロセス別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • 細胞処理
  • 細胞の保存・分配・ハンドリング
  • プロセス監視・品質管理
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第7章 細胞治療技術市場の分析:エンドユーザー別

  • 主要調査結果
  • 市場魅力度指数
  • 市場規模の推移・予測
  • バイオ医薬品・バイオテクノロジー企業
  • CRO・研究機関・細胞バンク
    • 市場規模の推移・予測:地域別
    • 市場シェア:地域別

第8章 細胞治療技術市場の分析:地域別

  • 主要調査結果
  • 市場規模の推移・予測

第9章 北米の細胞治療技術市場の分析

第10章 欧州の細胞治療技術市場の分析

第11章 アジア太平洋の細胞治療技術市場の分析

第12章 ラテンアメリカの細胞治療技術市場の分析

第13章 中東・アフリカの細胞治療技術市場の分析

第14章 企業プロファイル

  • Thermo Fisher Scientific Inc.
  • Novartis AG
  • Gilead Sciences, Inc.
  • Merck KGaA
  • Danaher Corporation
  • Bristol-Myers Squibb Company
  • Sartorius AG
  • FUJIFILM Diosynth Biotechnologies
  • Lonza
  • GE Healthcare
  • Terumo BCT
  • Avantor, Inc.
  • Bio-Techne Corporation
  • Corning Incorporated

第15章 総論・提言

  • Visiongainによる総論
  • 推奨事項
図表

List of Tables

  • Table 1 Cell Therapy Technologies Market Snapshot, 2024 & 2034 (US$ million, CAGR %)
  • Table 2 Cell Therapy Technologies Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 3 Cell Therapy Technologies Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 4 Cell Therapy Technologies Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 5 Cell Therapy Technologies Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 6 Cell Therapy Technologies Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 7 Sera, Media, Reagents Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 8 Cell Engineering Products Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 9 Cell Culture Vessels Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 10 Equipment Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 11 Systems and Software Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 12 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 13 Cell Therapy Technologies Market Forecast by Cell Type, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 14 T-Cells Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 15 Stem Cells Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 16 Other Cells Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 17 Cell Therapy Technologies Market Forecast by Process, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 18 Cardiovascular Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 19 Cell Preservation, Distribution, and Handling Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 20 Process Monitoring and Quality Control Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 21 Cell Therapy Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 22 Biopharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 23 CROs, Research Institutes and Cell Banks Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 24 Cell Therapy Technologies Market Forecast by Region, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 25 North America Cell Therapy Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 26 North America Cell Therapy Technologies Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 27 North America Cell Therapy Technologies Market Forecast by Cell Type, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 28 North America Cell Therapy Technologies Market Forecast by Process, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 29 North America Cell Therapy Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 30 U.S. Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 31 Canada Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 32 Europe Cell Therapy Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 33 Europe Cell Therapy Technologies Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 34 Europe Cell Therapy Technologies Market Forecast by Cell Type, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 35 Europe Cell Therapy Technologies Market Forecast by Process, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 36 Europe Cell Therapy Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 37 Germany Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 38 UK Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 39 France Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 40 Italy Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 41 Spain Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 42 Russia Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 43 Rest of Europe Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 44 Asia Pacific Cell Therapy Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 45 Asia Pacific Cell Therapy Technologies Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 46 Asia Pacific Cell Therapy Technologies Market Forecast by Cell Type, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 47 Asia Pacific Cell Therapy Technologies Market Forecast by Process, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 48 Asia Pacific Cell Therapy Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 49 Japan Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 50 China Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 51 India Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 52 Australia Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 53 South Korea Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 54 South-East Asia Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 55 Rest of Asia Pacific Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 56 Latin America Cell Therapy Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 57 Latin America Cell Therapy Technologies Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 58 Latin America Cell Therapy Technologies Market Forecast by Cell Type, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 59 Latin America Cell Therapy Technologies Market Forecast by Process, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 60 Latin America Cell Therapy Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 61 Brazil Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 62 Mexico Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 63 Rest of Latin America Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 64 MEA Cell Therapy Technologies Market Forecast by Country, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 65 MEA Cell Therapy Technologies Market Forecast by Product, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 66 MEA Cell Therapy Technologies Market Forecast by Cell Type, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 67 MEA Cell Therapy Technologies Market Forecast by Process, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 68 MEA Cell Therapy Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 69 GCC Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 70 South Africa Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 71 Rest of MEA Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR%, CAGR%)
  • Table 72 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 73 Thermo Fisher Scientific Inc.: Product Benchmarking
  • Table 74 Thermo Fisher Scientific Inc.: Strategic Outlook
  • Table 75 Novartis AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 76 Novartis AG: Product Benchmarking
  • Table 77 Novartis AG: Strategic Outlook
  • Table 78 Gilead Sciences, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 79 Gilead Sciences, Inc.: Product Benchmarking
  • Table 80 Gilead Sciences, Inc.: Strategic Outlook
  • Table 81 Merck KGaA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 82 Merck KGaA: Product Benchmarking
  • Table 83 Merck KGaA: Strategic Outlook
  • Table 84 Danaher Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 85 Danaher Corporation: Product Benchmarking
  • Table 86 Danaher Corporation: Strategic Outlook
  • Table 87 Bristol-Myers Squibb Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 88 Bristol-Myers Squibb Company: Product Benchmarking
  • Table 89 Bristol-Myers Squibb Company: Strategic Outlook
  • Table 90 Sartorius AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 91 Sartorius AG: Product Benchmarking
  • Table 92 Sartorius AG: Strategic Outlook
  • Table 93 FUJIFILM Diosynth Biotechnologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 94 FUJIFILM Diosynth Biotechnologies: Product Benchmarking
  • Table 95 FUJIFILM Diosynth Biotechnologies: Strategic Outlook
  • Table 96 Lonza: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 97 Lonza: Product Benchmarking
  • Table 98 Lonza: Strategic Outlook
  • Table 99 GE Healthcare: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 100 GE Healthcare: Product Benchmarking
  • Table 101 Terumo BCT: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 102 Terumo BCT: Product Benchmarking
  • Table 103 Terumo BCT: Strategic Outlook
  • Table 104 Avantor, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 105 Avantor, Inc.: Product Benchmarking
  • Table 106 Avantor, Inc.: Strategic Outlook
  • Table 107 Bio-Techne Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 108 Bio-Techne Corporation: Product Benchmarking
  • Table 109 Bio-Techne Corporation: Strategic Outlook
  • Table 110 Corning Incorporated: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 111 Corning Incorporated: Product Benchmarking
  • Table 112 Corning Incorporated: Strategic Outlook

List of Figures

  • Figure 1 Cell Therapy Technologies Market Segmentation
  • Figure 2 Cell Therapy Technologies Market by Product: Market Attractiveness Index
  • Figure 3 Cell Therapy Technologies Market by Cell Type: Market Attractiveness Index
  • Figure 4 Cell Therapy Technologies Market by Process: Market Attractiveness Index
  • Figure 5 Cell Therapy Technologies Market by End-users: Market Attractiveness Index
  • Figure 6 Cell Therapy Technologies Market Attractiveness Index by Region
  • Figure 7 Cell Therapy Technologies Market: Market Dynamics
  • Figure 8 Cell Therapy Technologies Market by Region, 2024-2034 (US$ Million, AGR %): "V" Shaped Recovery
  • Figure 9 Cell Therapy Technologies Market by Region, 2024-2034 (US$ Million, AGR %): "U" Shaped Recovery
  • Figure 10 Cell Therapy Technologies Market by Region, 2024-2034 (US$ Million, AGR %): "W" Shaped Recovery
  • Figure 11 Cell Therapy Technologies Market by Region, 2024-2034 (US$ Million, AGR %): "L" Shaped Recovery
  • Figure 12 Cell Therapy Technologies Market: Porter's Five Forces Analysis
  • Figure 13 Cell Therapy Technologies Market: PEST Analysis
  • Figure 14 Cell Therapy Technologies Market Attractiveness Index by Product
  • Figure 15 Cell Therapy Technologies Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 16 Cell Therapy Technologies Market Share Forecast by Product, 2024, 2029, 2034 (%)
  • Figure 17 Sera, Media, Reagent Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 18 Sera, Media, Reagent Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 19 Cell Engineering Product Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 20 Cell Engineering Product Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 21 Cell Culture Vessels Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 22 Cell Culture Vessels Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 23 Equipment Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 24 Equipment Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 25 Systems and Software Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 26 Systems and Software Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 27 Others Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 28 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 29 Cell Therapy Technologies Market Attractiveness Index by Product
  • Figure 30 Cell Therapy Technologies Market Forecast by Cell Type, 2024-2034 (US$ Million, AGR %)
  • Figure 31 Cell Therapy Technologies Market Share Forecast by Cell Type, 2024, 2029, 2034 (%)
  • Figure 32 T-Cells Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 33 T-Cells Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 34 Stem Cells Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 35 Stem Cells Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 36 Other Cells Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 37 Other Cells Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 38 Cell Therapy Technologies Market Attractiveness Index by Process
  • Figure 39 Cell Therapy Technologies Market Forecast by Process, 2024-2034 (US$ Million, AGR %)
  • Figure 40 Cell Therapy Technologies Market Share Forecast by Process, 2024, 2029, 2034 (%)
  • Figure 41 Cell Processing Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 42 Cell Processing Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 43 Cell Preservation, Distribution, and Handling Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 44 Cell Preservation, Distribution, and Handling Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 45 Process Monitoring and Quality Control Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 46 Process Monitoring and Quality Control Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 47 Cell Therapy Technologies Market Attractiveness Index by End-users
  • Figure 48 Cell Therapy Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
  • Figure 49 Cell Therapy Technologies Market Share Forecast by End-users, 2024, 2029, 2034 (%)
  • Figure 50 Biopharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 51 Biopharmaceutical & Biotechnology Companies Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 52 CROs, Research Institutes and Cell Banks Segment Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
  • Figure 53 CROs, Research Institutes and Cell Banks Segment Market Share Forecast by Region, 2024 & 2034 (%)
  • Figure 54 Cell Therapy Technologies Market Forecast by Region 2024, 2029, 2034 (Revenue, CAGR%)
  • Figure 55 Cell Therapy Technologies Market Share Forecast by Region 2024, 2029, 2034 (%)
  • Figure 56 Cell Therapy Technologies Market by Region, 2024-2034 (US$ Mn)
  • Figure 57 North America Cell Therapy Technologies Market Attractiveness Index
  • Figure 58 North America Cell Therapy Technologies Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 59 North America Cell Therapy Technologies Market Forecast by Country, 2024-2034 (US$ million)
  • Figure 60 North America Cell Therapy Technologies Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 61 North America Cell Therapy Technologies Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 62 North America Cell Therapy Technologies Market Share Forecast by Product, 2024 & 2034 (%)
  • Figure 63 North America Cell Therapy Technologies Market Forecast by Cell Type, 2024-2034 (US$ Million, AGR %)
  • Figure 64 North America Cell Therapy Technologies Market Share Forecast by Cell Type, 2024 & 2034 (%)
  • Figure 65 North America Cell Therapy Technologies Market Forecast by Process, 2024-2034 (US$ Million, AGR %)
  • Figure 66 North America Cell Therapy Technologies Market Share Forecast by Process, 2024 & 2034 (%)
  • Figure 67 North America Cell Therapy Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
  • Figure 68 North America Cell Therapy Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
  • Figure 69 U.S. Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 70 Canada Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 71 Europe Cell Therapy Technologies Market Attractiveness Index
  • Figure 72 Europe Cell Therapy Technologies Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 73 Europe Cell Therapy Technologies Market Forecast by Country, 2024-2034 (US$ million)
  • Figure 74 Europe Cell Therapy Technologies Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 75 Europe Cell Therapy Technologies Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 76 Europe Cell Therapy Technologies Market Share Forecast by Product, 2024 & 2034 (%)
  • Figure 77 Europe Cell Therapy Technologies Market Forecast by Cell Type, 2024-2034 (US$ Million, AGR %)
  • Figure 78 Europe Cell Therapy Technologies Market Share Forecast by Cell Type, 2024 & 2034 (%)
  • Figure 79 Europe Cell Therapy Technologies Market Forecast by Process, 2024-2034 (US$ Million, AGR %)
  • Figure 80 Europe Cell Therapy Technologies Market Share Forecast by Process, 2024 & 2034 (%)
  • Figure 81 Europe Cell Therapy Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
  • Figure 82 Europe Cell Therapy Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
  • Figure 83 Germany Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 84 UK Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 85 France Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 86 Italy Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 87 Spain Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 88 Russia Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 89 Rest of Europe Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 90 Asia Pacific Cell Therapy Technologies Market Attractiveness Index
  • Figure 91 Asia Pacific Cell Therapy Technologies Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 92 Asia Pacific Cell Therapy Technologies Market Forecast by Country, 2024-2034 (US$ million)
  • Figure 93 Asia Pacific Cell Therapy Technologies Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 94 Asia Pacific Cell Therapy Technologies Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 95 Asia Pacific Cell Therapy Technologies Market Share Forecast by Product, 2024 & 2034 (%)
  • Figure 96 Asia Pacific Cell Therapy Technologies Market Forecast by Cell Type, 2024-2034 (US$ Million, AGR %)
  • Figure 97 Asia Pacific Cell Therapy Technologies Market Share Forecast by Cell Type, 2024 & 2034 (%)
  • Figure 98 Asia Pacific Cell Therapy Technologies Market Forecast by Process, 2024-2034 (US$ Million, AGR %)
  • Figure 99 Asia Pacific Cell Therapy Technologies Market Share Forecast by Process, 2024 & 2034 (%)
  • Figure 100 Asia Pacific Cell Therapy Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
  • Figure 101 Asia Pacific Cell Therapy Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
  • Figure 102 Japan Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 103 China Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 104 India Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 105 Australia Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 106 South Korea Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 107 South-East Asia Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 108 Rest of Asia Pacific Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 109 Latin America Cell Therapy Technologies Market Attractiveness Index
  • Figure 110 Latin America Cell Therapy Technologies Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 111 Latin America Cell Therapy Technologies Market Forecast by Country, 2024-2034 (US$ million)
  • Figure 112 Latin America Cell Therapy Technologies Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 113 Latin America Cell Therapy Technologies Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 114 Latin America Cell Therapy Technologies Market Share Forecast by Product, 2024 & 2034 (%)
  • Figure 115 Latin America Cell Therapy Technologies Market Forecast by Cell Type, 2024-2034 (US$ Million, AGR %)
  • Figure 116 Latin America Cell Therapy Technologies Market Share Forecast by Cell Type, 2024 & 2034 (%)
  • Figure 117 Latin America Cell Therapy Technologies Market Forecast by Process, 2024-2034 (US$ Million, AGR %)
  • Figure 118 Latin America Cell Therapy Technologies Market Share Forecast by Process, 2024 & 2034 (%)
  • Figure 119 Latin America Cell Therapy Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
  • Figure 120 Latin America Cell Therapy Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
  • Figure 121 Brazil Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 122 Mexico Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 123 Rest of Latin America Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 124 MEA Cell Therapy Technologies Market Attractiveness Index
  • Figure 125 MEA Cell Therapy Technologies Market by Region, 2024, 2029 & 2034 (US$ Million)
  • Figure 126 MEA Cell Therapy Technologies Market Forecast by Country, 2024-2034 (US$ million)
  • Figure 127 MEA Cell Therapy Technologies Market Share Forecast by Country, 2024 & 2034 (%)
  • Figure 128 MEA Cell Therapy Technologies Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
  • Figure 129 MEA Cell Therapy Technologies Market Share Forecast by Product, 2024 & 2034 (%)
  • Figure 130 MEA Cell Therapy Technologies Market Forecast by Cell Type, 2024-2034 (US$ Million, AGR %)
  • Figure 131 MEA Cell Therapy Technologies Market Share Forecast by Cell Type, 2024 & 2034 (%)
  • Figure 132 MEA Cell Therapy Technologies Market Forecast by Process, 2024-2034 (US$ Million, AGR %)
  • Figure 133 MEA Cell Therapy Technologies Market Share Forecast by Process, 2024 & 2034 (%)
  • Figure 134 MEA Cell Therapy Technologies Market Forecast by End-users, 2024-2034 (US$ Million, AGR %)
  • Figure 135 MEA Cell Therapy Technologies Market Share Forecast by End-users, 2024 & 2034 (%)
  • Figure 136 GCC Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 137 South Africa Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 138 Rest of MEA Cell Therapy Technologies Market Forecast, 2024-2034 (US$ Million, AGR %)
  • Figure 139 Thermo Fisher Scientific Inc.: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 140 Thermo Fisher Scientific Inc.: Regional Market Shares (%), 2022
  • Figure 141 Thermo Fisher Scientific Inc.: R&D, 2018-2023 (US$ Million, AGR%)
  • Figure 142 Novartis AG: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 143 Novartis AG: Regional Market Shares (%), 2022
  • Figure 144 Novartis AG: R&D, 2018-2023 (US$ Million, AGR%)
  • Figure 145 Gilead Sciences, Inc.: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 146 Gilead Sciences, Inc.: R&D, 2018-2023 (US$ Million, AGR%)
  • Figure 147 Merck KGaA: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 148 Merck KGaA: Regional Market Shares (%), 2023
  • Figure 149 Merck KGaA: R&D, 2018-2023 (US$ Million, AGR%)
  • Figure 150 Danaher Corporation: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 151 Danaher Corporation: Regional Market Shares (%), 2023
  • Figure 152 Danaher Corporation: R&D, 2018-2023 (US$ Million, AGR%)
  • Figure 153 Bristol-Myers Squibb Company: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 154 Bristol-Myers Squibb Company: Regional Market Shares (%), 2023
  • Figure 155 Bristol-Myers Squibb Company: R&D, 2018-2023 (US$ Million, AGR%)
  • Figure 156 Sartorius AG: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 157 Sartorius AG: Regional Market Shares (%), 2023
  • Figure 158 Sartorius AG: R&D, 2018-2023 (US$ Million, AGR%)
  • Figure 159 Lonza: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 160 Lonza: Regional Market Shares (%), 2023
  • Figure 161 Lonza: R&D, 2018-2022 (US$ Million, AGR%)
  • Figure 162 GE Healthcare: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 163 GE Healthcare: Regional Market Shares (%), 2022
  • Figure 164 GE Healthcare: R&D, 2018-2023 (US$ Million, AGR%)
  • Figure 165 Terumo BCT: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 166 Terumo BCT: Regional Market Shares (%), 2022
  • Figure 167 Avantor, Inc.: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 168 Avantor, Inc.: Regional Market Shares (%), 2023
  • Figure 169 Bio-Techne Corporation: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 170 Bio-Techne Corporation: R&D, 2018-2023 (US$ Million, AGR%)
  • Figure 171 Corning Incorporated: Net Revenue, 2018-2023 (US$ Million, AGR%)
  • Figure 172 Corning Incorporated: Regional Market Shares (%), 2023
  • Figure 173 Corning Incorporated: R&D, 2018-2023 (US$ Million, AGR%)
目次
Product Code: PHA1320

The global Cell Therapy Technologies market is projected to grow at a CAGR of 10.7% by 2034

The Cell Therapy Technologies Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Integration of Automation and Robotics into Manufacturing Processes Driving Industry Growth

The integration of automation & robotics within manufacturing sector is propelling the adoption of cell therapy technology. This fusion enhances efficiency, scalability, and reproducibility, while simultaneously mitigating contamination risks. The heightened utilization of closed system bioprocessing technologies further tackles manufacturing challenges by bolstering sterility and safety, all with minimal human intervention.

Nevertheless, obstacles such as steep development costs, intricate manufacturing processes, regulatory complexities, and restricted reimbursement policies pose potential hindrances to industry expansion. To surmount these barriers, there's an escalating demand for cutting-edge analytical tools geared toward quality control and process optimization.

The integration of innovative assays, imaging techniques, and data analytics facilitates real-time monitoring and characterization of cellular products, thereby ensuring heightened efficacy and safety. Additionally, the focus on pioneering biomaterials and scaffolds enhances cell delivery and engraftment, thereby augmenting the allure of cell therapy technologies. Regulatory advancements & collaborations between industry stakeholders & research bodies are fostering innovation and accelerating the transition of cell therapy technologies from laboratory settings to clinical application.

What Questions Should You Ask before Buying a Market Research Report?

How is the cell therapy technologies market evolving?

What is driving and restraining the cell therapy technologies market?

How will each cell therapy technologies submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?

How will the market shares for each cell therapy technologies submarket develop from 2024 to 2034?

What will be the main driver for the overall market from 2024 to 2034?

Will leading cell therapy technologies markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?

How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?

Who are the leading players and what are their prospects over the forecast period?

What are the cell therapy technologies projects for these leading companies?

How will the industry evolve during the period between 2024 and 2034? What are the implications of

cell therapy technologies projects taking place now and over the next 10 years?

Is there a greater need for product commercialisation to further scale the cell therapy technologies market?

Where is the cell therapy technologies market heading and how can you ensure you are at the forefront of the market?

What are the best investment options for new product and service lines?

What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the cell therapy technologies market today, and over the next 10 years:

Our 305-page report provides 109 tables and 173 charts/graphs exclusively to you.

The report highlights key lucrative areas in the industry so you can target them - NOW.

It contains in-depth analysis of global, regional and national sales and growth.

It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the cell therapy technologies market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects

In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.

You will find original analyses, with business outlooks and developments.

Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report

Product

Sera, Media, Reagent

Cell Engineering Product

Cell Culture Vessels

Equipment

Systems and Software

Others

Cell Type

T-Cells

Stem Cells

Other Cells

Process

Cell Processing

Cell Preservation, Distribution, and Handling

Process Monitoring and Quality Control

End-users

Biopharmaceutical & Biotechnology Companies

CROs, Research Institutes and Cell Banks

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets:

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

Asia Pacific

Japan

China

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

MEA

GCC

South Africa

Rest of MEA

The report also includes profiles and for some of the leading companies in the Cell Therapy Technologies Market, 2024 to 2034, with a focus on this segment of these companies' operations.

Leading companies profiled in the report

Avantor, Inc.

Bio-Techne Corporation

Bristol-Myers Squibb Company

Corning Incorporated

Danaher Corporation

FUJIFILM Diosynth Biotechnologies

GE Healthcare

Gilead Sciences, Inc.

Lonza

Merck KGaA

Novartis AG

Sartorius AG

Terumo BCT

Thermo Fisher Scientific Inc.

Overall world revenue for Cell Therapy Technologies Market, 2024 to 2034 in terms of value the market will surpass US$7,040 million in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Cell Therapy Technologies Market, 2024 to 2034 report help you?

In summary, our 300+ page report provides you with the following knowledge:

Revenue forecasts to 2034 for Cell Therapy Technologies Market 2024 to 2034, with forecasts for product, cell type, process, and end-users, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.

Revenue forecasts to 2034 for five regional and 22 key national markets - See forecasts for the Cell Therapy Technologies Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.

Prospects for established firms and those seeking to enter the market - including company profiles for 13 of the major companies involved in the Cell Therapy Technologies Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Cell Therapy Technologies Market 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Cell Therapy Technologies Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Advancements in Cellular Biology
      • 3.2.1.2 Increasing Government Investments in Cell-based Research
      • 3.2.1.3 Technological Advancements
      • 3.2.1.4 Increasing GMP Certifications for Cell Therapy Production Facilities
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Challenges Associated with Manufacturing Likely to Restrain Industry Growth
      • 3.2.2.2 Low Success Rate
      • 3.2.2.3 Logistical Challenges Projected to Hamper Industry Growth
    • 3.2.3 Market Opportunities
      • 3.2.3.1 Increased Focus on Personalized Medicine
      • 3.2.3.2 Emergence of iPSCs as Alternatives to ESCs
      • 3.2.3.3 Integration of Digital Health Technologies
      • 3.2.3.4 Expanded Therapeutic Applications
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Supplier Power
    • 3.4.2 Buyer Power
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat of Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 Cell Therapy Technologies Market Analysis by Product

  • 4.1 Key Findings
  • 4.2 Product Segment: Market Attractiveness Index
  • 4.3 Cell Therapy Technologies Market Size Estimation and Forecast by Product
  • 4.4 Sera, Media, Reagent
    • 4.4.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
    • 4.4.2 Market Share by Region, 2024 & 2034 (%)
  • 4.5 Cell Engineering Product
    • 4.5.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
    • 4.5.2 Market Share by Region, 2024 & 2034 (%)
  • 4.6 Cell Culture Vessels
    • 4.6.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
    • 4.6.2 Market Share by Region, 2024 & 2034 (%)
  • 4.7 Equipment
    • 4.7.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
    • 4.7.2 Market Share by Region, 2024 & 2034 (%)
  • 4.8 Systems and Software
    • 4.8.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
    • 4.8.2 Market Share by Region, 2024 & 2034 (%)
  • 4.9 Others
    • 4.9.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
    • 4.9.2 Market Share by Region, 2024 & 2034 (%)

5 Cell Therapy Technologies Market Analysis by Cell Type

  • 5.1 Key Findings
  • 5.2 Cell Type Segment: Market Attractiveness Index
  • 5.3 Cell Therapy Technologies Market Size Estimation and Forecast by Cell Type
  • 5.4 T-Cells
    • 5.4.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
    • 5.4.2 Market Share by Region, 2024 & 2034 (%)
  • 5.5 Stem Cells
    • 5.5.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
    • 5.5.2 Market Share by Region, 2024 & 2034 (%)
  • 5.6 Other Cells
    • 5.6.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
    • 5.6.2 Market Share by Region, 2024 & 2034 (%)

6 Cell Therapy Technologies Market Analysis by Process

  • 6.1 Key Findings
  • 6.2 Process Segment: Market Attractiveness Index
  • 6.3 Cell Therapy Technologies Market Size Estimation and Forecast by Process
  • 6.4 Cell Processing
    • 6.4.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
    • 6.4.2 Market Share by Region, 2024 & 2034 (%)
  • 6.5 Cell Preservation, Distribution, and Handling
    • 6.5.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
    • 6.5.2 Market Share by Region, 2024 & 2034 (%)
  • 6.6 Process Monitoring and Quality Control
    • 6.6.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
    • 6.6.2 Market Share by Region, 2024 & 2034 (%)

7 Cell Therapy Technologies Market Analysis by End-users

  • 7.1 Key Findings
  • 7.2 End-users Segment: Market Attractiveness Index
  • 7.3 Cell Therapy Technologies Market Size Estimation and Forecast by End-users
  • 7.4 Biopharmaceutical & Biotechnology Companies
    • 7.4.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
    • 7.4.2 Market Share by Region, 2024 & 2034 (%)
  • 7.5 CROs, Research Institutes and Cell Banks
    • 7.5.1 Market Forecast by Region, 2024-2034 (US$ Million, AGR %)
    • 7.5.2 Market Share by Region, 2024 & 2034 (%)

8 Cell Therapy Technologies Market Analysis by Region

  • 8.1 Key Findings
  • 8.2 Regional Market Size Estimation and Forecast

9 North America Cell Therapy Technologies Market Analysis

  • 9.1 Key Findings
  • 9.2 North America Cell Therapy Technologies Market Attractiveness Index
  • 9.3 North America Cell Therapy Technologies Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 9.4 North America Cell Therapy Technologies Market Size Estimation and Forecast by Country
  • 9.5 North America Cell Therapy Technologies Market Size Estimation and Forecast by Product
  • 9.6 North America Cell Therapy Technologies Market Size Estimation and Forecast by Cell Type
  • 9.7 North America Cell Therapy Technologies Market Size Estimation and Forecast by Process
  • 9.8 North America Cell Therapy Technologies Market Size Estimation and Forecast by End-users
  • 9.9 U.S. Cell Therapy Technologies Market Analysis
  • 9.10 Canada Cell Therapy Technologies Market Analysis

10 Europe Cell Therapy Technologies Market Analysis

  • 10.1 Key Findings
  • 10.2 Europe Cell Therapy Technologies Market Attractiveness Index
  • 10.3 Europe Cell Therapy Technologies Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 10.4 Europe Cell Therapy Technologies Market Size Estimation and Forecast by Country
  • 10.5 Europe Cell Therapy Technologies Market Size Estimation and Forecast by Product
  • 10.6 Europe Cell Therapy Technologies Market Size Estimation and Forecast by Cell Type
  • 10.7 Europe Cell Therapy Technologies Market Size Estimation and Forecast by Process
  • 10.8 Europe Cell Therapy Technologies Market Size Estimation and Forecast by End-users
  • 10.9 Germany Cell Therapy Technologies Market Analysis
  • 10.10 UK Cell Therapy Technologies Market Analysis
  • 10.11 France Cell Therapy Technologies Market Analysis
  • 10.12 Italy Cell Therapy Technologies Market Analysis
  • 10.13 Spain Cell Therapy Technologies Market Analysis
  • 10.14 Russia Cell Therapy Technologies Market Analysis
  • 10.15 Rest of Europe Cell Therapy Technologies Market Analysis

11 Asia Pacific Cell Therapy Technologies Market Analysis

  • 11.1 Key Findings
  • 11.2 Asia Pacific Cell Therapy Technologies Market Attractiveness Index
  • 11.3 Asia Pacific Cell Therapy Technologies Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 11.4 Asia Pacific Cell Therapy Technologies Market Size Estimation and Forecast by Country
  • 11.5 Asia Pacific Cell Therapy Technologies Market Size Estimation and Forecast by Product
  • 11.6 Asia Pacific Cell Therapy Technologies Market Size Estimation and Forecast by Cell Type
  • 11.7 Asia Pacific Cell Therapy Technologies Market Size Estimation and Forecast by Process
  • 11.8 Asia Pacific Cell Therapy Technologies Market Size Estimation and Forecast by End-users
  • 11.9 Japan Cell Therapy Technologies Market Analysis
  • 11.10 China Cell Therapy Technologies Market Analysis
  • 11.11 India Cell Therapy Technologies Market Analysis
  • 11.12 Australia Cell Therapy Technologies Market Analysis
  • 11.13 South Korea Cell Therapy Technologies Market Analysis
  • 11.14 South-East Asia Cell Therapy Technologies Market Analysis
  • 11.15 Rest of Asia Pacific Cell Therapy Technologies Market Analysis

12 Latin America Cell Therapy Technologies Market Analysis

  • 12.1 Key Findings
  • 12.2 Latin America Cell Therapy Technologies Market Attractiveness Index
  • 12.3 Latin America Cell Therapy Technologies Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 12.4 Latin America Cell Therapy Technologies Market Size Estimation and Forecast by Country
  • 12.5 Latin America Cell Therapy Technologies Market Size Estimation and Forecast by Product
  • 12.6 Latin America Cell Therapy Technologies Market Size Estimation and Forecast by Cell Type
  • 12.7 Latin America Cell Therapy Technologies Market Size Estimation and Forecast by Process
  • 12.8 Latin America Cell Therapy Technologies Market Size Estimation and Forecast by End-users
  • 12.9 Brazil Cell Therapy Technologies Market Analysis
  • 12.10 Mexico Cell Therapy Technologies Market Analysis
  • 12.11 Rest of Latin America Cell Therapy Technologies Market Analysis

13 MEA Cell Therapy Technologies Market Analysis

  • 13.1 Key Findings
  • 13.2 MEA Cell Therapy Technologies Market Attractiveness Index
  • 13.3 MEA Cell Therapy Technologies Market by Country, 2024, 2029 & 2034 (US$ Million)
  • 13.4 MEA Cell Therapy Technologies Market Size Estimation and Forecast by Country
  • 13.5 MEA Cell Therapy Technologies Market Size Estimation and Forecast by Product
  • 13.6 MEA Cell Therapy Technologies Market Size Estimation and Forecast by Cell Type
  • 13.7 MEA Cell Therapy Technologies Market Size Estimation and Forecast by Process
  • 13.8 MEA Cell Therapy Technologies Market Size Estimation and Forecast by End-users
  • 13.9 GCC Cell Therapy Technologies Market Analysis
  • 13.10 South Africa Cell Therapy Technologies Market Analysis
  • 13.11 Rest of MEA Cell Therapy Technologies Market Analysis

14 Company Profiles

  • 14.1 Thermo Fisher Scientific Inc.
    • 14.1.1 Company Snapshot
    • 14.1.2 Company Overview
    • 14.1.3 Financial Analysis
      • 14.1.3.1 Net Revenue, 2018-2023
      • 14.1.3.2 Regional Market Shares, 2022
      • 14.1.3.3 R&D, 2018-2023
    • 14.1.4 Product Benchmarking
    • 14.1.5 Strategic Outlook
  • 14.2 Novartis AG
    • 14.2.1 Company Snapshot
    • 14.2.2 Company Overview
    • 14.2.3 Financial Analysis
      • 14.2.3.1 Net Revenue, 2018-2023
      • 14.2.3.2 Regional Market Shares, 2022
      • 14.2.3.3 R&D, 2018-2023
    • 14.2.4 Product Benchmarking
    • 14.2.5 Strategic Outlook
  • 14.3 Gilead Sciences, Inc.
    • 14.3.1 Company Snapshot
    • 14.3.2 Company Overview
    • 14.3.3 Financial Analysis
      • 14.3.3.1 Net Revenue, 2018-2023
      • 14.3.3.2 R&D, 2018-2023
    • 14.3.4 Product Benchmarking
    • 14.3.5 Strategic Outlook
  • 14.4 Merck KGaA
    • 14.4.1 Company Snapshot
    • 14.4.2 Company Overview
    • 14.4.3 Financial Analysis
      • 14.4.3.1 Net Revenue, 2018-2023
      • 14.4.3.2 Regional Market Shares, 2023
      • 14.4.3.3 R&D, 2018-2023
    • 14.4.4 Product Benchmarking
    • 14.4.5 Strategic Outlook
  • 14.5 Danaher Corporation
    • 14.5.1 Company Snapshot
    • 14.5.2 Company Overview
    • 14.5.3 Financial Analysis
      • 14.5.3.1 Net Revenue, 2018-2023
      • 14.5.3.2 Regional Market Shares, 2023
      • 14.5.3.3 R&D, 2018-2023
    • 14.5.4 Product Benchmarking
    • 14.5.5 Strategic Outlook
  • 14.6 Bristol-Myers Squibb Company
    • 14.6.1 Company Snapshot
    • 14.6.2 Company Overview
    • 14.6.3 Financial Analysis
      • 14.6.3.1 Net Revenue, 2018-2023
      • 14.6.3.2 Regional Market Shares, 2023
      • 14.6.3.3 R&D, 2018-2023
    • 14.6.4 Product Benchmarking
    • 14.6.5 Strategic Outlook
  • 14.7 Sartorius AG
    • 14.7.1 Company Snapshot
    • 14.7.2 Company Overview
    • 14.7.3 Financial Analysis
      • 14.7.3.1 Net Revenue, 2018-2023
      • 14.7.3.2 Regional Market Shares, 2023
      • 14.7.3.3 R&D, 2018-2023
    • 14.7.4 Product Benchmarking
    • 14.7.5 Strategic Outlook
  • 14.8 FUJIFILM Diosynth Biotechnologies
    • 14.8.1 Company Snapshot
    • 14.8.2 Company Overview
    • 14.8.3 Product Benchmarking
    • 14.8.4 Strategic Outlook
  • 14.9 Lonza
    • 14.9.1 Company Snapshot
    • 14.9.2 Company Overview
    • 14.9.3 Financial Analysis
      • 14.9.3.1 Net Revenue, 2018-2023
      • 14.9.3.2 Regional Market Shares, 2023
      • 14.9.3.3 R&D, 2018-2022
    • 14.9.4 Product Benchmarking
    • 14.9.5 Strategic Outlook
  • 14.10 GE Healthcare
    • 14.10.1 Company Snapshot
    • 14.10.2 Company Overview
    • 14.10.3 Financial Analysis
      • 14.10.3.1 Net Revenue, 2018-2023
      • 14.10.3.2 Regional Market Shares, 2022
      • 14.10.3.3 R&D, 2018-2023
    • 14.10.4 Product Benchmarking
  • 14.11 Terumo BCT
    • 14.11.1 Company Snapshot
    • 14.11.2 Company Overview
    • 14.11.3 Financial Analysis
      • 14.11.3.1 Net Revenue, 2018-2023
      • 14.11.3.2 Regional Market Shares, 2022
    • 14.11.4 Product Benchmarking
    • 14.11.5 Strategic Outlook
  • 14.12 Avantor, Inc.
    • 14.12.1 Company Snapshot
    • 14.12.2 Company Overview
    • 14.12.3 Financial Analysis
      • 14.12.3.1 Net Revenue, 2018-2023
      • 14.12.3.2 Regional Market Shares, 2023
    • 14.12.4 Product Benchmarking
    • 14.12.5 Strategic Outlook
  • 14.13 Bio-Techne Corporation
    • 14.13.1 Company Snapshot
    • 14.13.2 Company Overview
    • 14.13.3 Financial Analysis
      • 14.13.3.1 Net Revenue, 2018-2023
      • 14.13.3.2 R&D, 2018-2023
    • 14.13.4 Product Benchmarking
    • 14.13.5 Strategic Outlook
  • 14.14 Corning Incorporated
    • 14.14.1 Company Snapshot
    • 14.14.2 Company Overview
    • 14.14.3 Financial Analysis
      • 14.14.3.1 Net Revenue, 2018-2023
      • 14.14.3.2 Regional Market Shares, 2023
      • 14.14.3.3 R&D, 2018-2023
    • 14.14.4 Product Benchmarking
    • 14.14.5 Strategic Outlook

15 Conclusion and Recommendations

  • 15.1 Concluding Remarks from Visiongain
  • 15.2 Recommendations for Market Players